IP Library Granted Patent US 8,119,404
Granted Patent B2
US 8,119,404 · App. 12/832,682 · Granted Feb 21, 2012

Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them

Assignee: Sanford-Burnham Medical Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,404
App. No.
12/832,682
Granted
Feb 21, 2012
Kind
B2
Abstract

The invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP initially derived from Bombyx mori BmN cells, and nucleic acids encoding them, and methods for making and using these compositions, including their use for inhibiting apoptosis.

Claims (10)

1. A method for identifying an agent that can modulate the activity of a polypeptide, wherein the polypeptide comprises a sequence having at least 95% sequence identity to SEQ ID NO:2 and is capable inhibiting apoptosis in a cell, comprising: (a) contacting a cell expressing the polypeptide recombinantly in the presence and absence of a test agent before, during or after inducing apoptosis in the cell; and (b) measuring the amount or degree of polypeptide activity in the cell in the presence and absence of the test agent, wherein an increase or decrease in the amount or degree of polypeptide activity in the cell in the presence of the test agent identifies the test agent as a modulator of the polypeptide's activity.

2. The method of claim 1 , wherein the cell is an insect cell.

3. The method of claim 2 , wherein the cell is a Bombyx mori cell.

4. The method of claim 1 , wherein the cell is a plant cell.

5. The method of claim 1 , wherein the cell is a mammalian cell.

6. The method of claim 1 , wherein the cell is a yeast cell.

7. The method of claim 1 , wherein the degree of polypeptide activity in the cell is determined by measuring the amount or degree of apoptosis in the cell.

8. The method of claim 1 , wherein the degree of polypeptide activity in the cell is determined by measuring the amount or degree of caspase protease activity in the cell.

9. The method of claim 1 , wherein the degree of polypeptide activity in the cell is determined by measuring the amount or degree of DNA fragmentation in the cell.

10. The method of claim 1 , wherein the degree of polypeptide activity in the cell is determined by measuring the amount or degree of cleavage of substrates of caspases in the cell.

Assignments (5)
CONFIRMATORY LICENSE Recorded Apr 11, 2024
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR; NATIONAL INSTITUTE OF FOOD AND AGRICULTURE, UNITED STATES DEPARTMENT OF AGRICULTURE
Reel/Frame 067077/0340 →
CHANGE OF NAME Recorded Dec 2, 2010
From: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
To: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Reel/Frame 025437/0445 →
CHANGE OF NAME Recorded Dec 2, 2010
From: THE BURNHAM INSTITUTE
To: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 025437/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2010
From: REED, JOHN C.; DEVERAUX, QUINN L.
To: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 024809/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2010
From: HAMMOCK, BRUCE D.; MAEDA, HIROKO; HUANG, QIHONG
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 024809/0339 →
Continuity (4)
Division 11623637 · Jan 16, 2007
Continuation 10041859 · Jan 7, 2002
Provisional Application 60260478 · Jan 8, 2001
Related Publication 20100275284A1 · Oct 28, 2010